Hexa Reports
This presentation is the property of its rightful owner.
Sponsored Links
1 / 4

Escherichia coli Infections Market Size, Share, Trends and Analysis PowerPoint PPT Presentation


  • 53 Views
  • Uploaded on
  • Presentation posted in: Industry

Global Markets Direct's, 'Escherichia coli Infections - Pipeline Review, H1 2016', provides an overview of the Escherichia coli Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Escherichia coli Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Download Presentation

Escherichia coli Infections Market Size, Share, Trends and A...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Escherichia coli infections market size share trends and analysis

Hexa Reports

Market Research Reports and Insightful Company Profiles

Escherichia coli Infections Market Size, Share, Global

Analysis, Trends, Outlook, Overview, Market Insights,

Pipeline Review, H1 2016

Global Markets Direct's, 'Escherichia coli Infections - Pipeline Review, H1 2016', provides an overview of

the Escherichia coli Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Escherichia

coli Infections, complete with analysis by stage of development, drug target, mechanism of action

(MoA), route of administration (RoA) and molecule type. The report also covers the descriptive

pharmacological action of the therapeutics, its complete research and development history and latest

news and press releases. Additionally, the report provides an overview of key players involved in

therapeutic development for Escherichia coli Infections and features dormant and discontinued

projects.

Browse Detail Report With TOC @ http://hexareports.com/report/escherichia-coli-infections-pipeline-

review-h1-2016/details

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy

areas and nearly 3,000 indications. The report is built using data and information sourced from Global

Markets Direct's proprietary databases, company/university websites, clinical trial registries,

conferences, SEC filings, investor presentations and featured press releases from company/university

sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic

review following a stringent set of processes to ensure that all the profiles are updated with the latest

set of information. Additionally, various dynamic tracking processes ensure that the most recent

developments are captured on a real time basis.


Escherichia coli infections market size share trends and analysis

Hexa Reports

Market Research Reports and Insightful Company Profiles

The report helps in identifying and tracking emerging players in the market and their portfolios,

enhances decision making capabilities and helps to create effective counter strategies to gain

competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance

of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Escherichia coli Infections

- The report reviews pipeline therapeutics for Escherichia coli Infections by companies and

universities/research institutes based on information derived from company and industry-specific

sources

- The report covers pipeline products based on various stages of development ranging from pre-

registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product

description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental

activities

- The report reviews key players involved Escherichia coli Infections therapeutics and enlists all their

major and minor projects

- The report assesses Escherichia coli Infections therapeutics based on drug target, mechanism of action

(MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Escherichia coli Infections

Reasons To Buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D

strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-

strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for

Escherichia coli Infections

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline

therapeutics

- Devise corrective measures for pipeline projects by understanding Escherichia coli Infections pipeline

depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with

the most attractive projects to enhance and expand business potential and Scope


Escherichia coli infections market size share trends and analysis

Hexa Reports

Market Research Reports and Insightful Company Profiles

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors

that drove them from pipeline

Request A Sample copy of This Report @ http://hexareports.com/sample/135393

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 8

Introduction 9

Global Markets Direct Report Coverage 9

Escherichia coli Infections Overview 10

Therapeutics Development 11

Pipeline Products for Escherichia coli Infections - Overview 11

Pipeline Products for Escherichia coli Infections - Comparative Analysis 12

Escherichia coli Infections - Therapeutics under Development by Companies 13

Escherichia coli Infections - Therapeutics under Investigation by Universities/Institutes 15

Escherichia coli Infections - Pipeline Products Glance 16

Clinical Stage Products 16

Early Stage Products 17

Escherichia coli Infections - Products under Development by Companies 18

Escherichia coli Infections - Products under Investigation by Universities/Institutes 21

Escherichia coli Infections - Companies Involved in Therapeutics Development 22

Adenium Biotech ApS 22

Arsanis Biosciences GmbH 23

AstraZeneca Plc 24

AvidBiotics Corp. 25

Bioorganic Research and Services S.A. 26

Cellceutix Corporation 27

Cytovation AS 28

Debiopharm International SA 29

Emergent BioSolutions Inc. 30

Browse Full Report @ http://hexareports.com/report/escherichia-coli-infections-pipeline-review-h1-

2016/details

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom

research and consulting services to a host of key industries across the globe. We offer comprehensive


Escherichia coli infections market size share trends and analysis

Hexa Reports

Market Research Reports and Insightful Company Profiles

business intelligence in the form of industry reports which help our clients obtain clarity about their

business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,

6265 Highway 9,

Felton, California, 95018,

United States

Phone Number

1-800-489-3075

Email Us: [email protected]

Our Website: http://www.hexareports.com/

Visit Our Blogs: http://hexareports.blogspot.in


  • Login